Synthetic and Semi-synthetic Drugs as a Promising Therapeutic Option for the Treatment of COVID-19
Ekta Shirbhate(Guru Ghasidas Vishwavidyalaya), Harish Rajak(Guru Ghasidas Vishwavidyalaya), Vijay K. Patel(Guru Ghasidas Vishwavidyalaya), Prabodh Chander Sharma(Delhi Pharmaceutical Science and Research University), Ravichandran Veerasamy(Guru Ghasidas Vishwavidyalaya), Preeti Patel(Indo Soviet Friendship College of Pharmacy), Barij Nayan Sinha(Birla Institute of Technology, Mesra)
Cited by 2
Related Papers
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs
|Life|2023|209
Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention
|Pharmacological Reports|2021|145
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
|Drug Delivery and Translational Research|2024|141
Quinoline‐derivatives as privileged scaffolds for medicinal and pharmaceutical chemists: A comprehensive review
|Chemical Biology & Drug Design|2022|92
Alternatives of Animal Models for Biomedical Research: a Comprehensive Review of Modern Approaches
|Stem Cell Reviews and Reports|2024|85